Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer

Clinical trial NCT03754933 · COMPLETED

Trial details

NCT number: NCT03754933
Sponsor: GeoVax, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Head and Neck Cancer

Start date: 2019-02-11
Primary completion: 2023-12-29
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.